Enliven Therapeutics ELVN
NASDAQ ELVN
$41.81 +0.56 (+1.36%)
As of: Oct 21, 2026 · 3:59 PM EDT

Enliven Therapeutics (ELVN) EBIT Margin (2019 - 2026)

Updated

Analysis

Enliven Therapeutics (ELVN) EBIT Margin (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Enliven Therapeutics 2.77 Bn 482.20 Mn - -786.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -786.33%
Mar 31, 2026 -663.08%
Dec 31, 2025 -742.42%
Sep 30, 2025 -507.19%
Jun 30, 2025 -879.24%
Mar 31, 2025 -991.65%
Dec 31, 2024 -723.79%
Sep 30, 2024 -705.08%
Jun 30, 2024 -602.13%
Mar 31, 2024 -799.60%
Dec 31, 2023 -674.85%
Sep 30, 2023 -694.39%
Jun 30, 2023 -589.92%
Mar 31, 2023 -969.19%
Dec 31, 2022 -1,657.91%
Sep 30, 2022 -2,877.37%
Jun 30, 2022 -7,099.21%
Mar 31, 2022 -96,422.22%
Dec 31, 2021 -19,908.33%
Sep 30, 2021 -45,530.00%
API Access

Enliven Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ELVN&period=max&api_key=YOUR_API_KEY